mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.7 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.7 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.7 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |